Stevanato Group is a medical - instruments & supplies company in the healthcare sector trading on NYSE, led by CEO Franco Stevanato, with a market cap of $3.8B.
Common questions about Stevanato Group
Stevanato Group is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $311.1M.
Stevanato Group has approximately 5,635 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.